Genomic Assay Changes Minds on HER2+ Breast Cancer Treatment
Genomic Assay Changes Minds on HER2+ Breast Cancer Treatment
https://www.medscape.com/s/viewarticle/992154 HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial https://www.thelancet.com/journals/e...502-3/fulltext Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab https://jamanetwork.com/journals/jam...stract/2804135 https://www.reveal-genomics.com/her2dx |
All times are GMT -7. The time now is 05:59 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021